Pérez Lloret, S., & Rascol, O. (2016). The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease. Web
Citación estilo ChicagoPérez Lloret, Santiago, and Olivier Rascol. The Safety and Efficacy of Safinamide Mesylate for the Treatment of Parkinson’s Disease. 2016.
Cita MLAPérez Lloret, Santiago, and Olivier Rascol. The Safety and Efficacy of Safinamide Mesylate for the Treatment of Parkinson’s Disease. 2016.
Precaución: Estas citas no son 100% exactas.